DC1: Design and discovery of novel GrnzB ligands and evaluation as diagnostics tools in CAR T cell therapy assessment
DC2: Novel probes for imaging of tumor-associated proteases via Positron Emission Tomography (PET) and fluorescence microscopy
DC3: : Innovative Target Modulators (TMs) for simultaneous delivery of CAR T cell therapy, radio- and chemotherapy to tumors
DC4: Innovative Target Modulators for FAP-targeting UniCAR T therapy
DC5: Design and discovery of novel cathepsin S ligands and their evaluation as PET and fluorescent probes for oncology diagnosis (
DC6: Characterization of the p38 MAPK pathway in the expression of TME proteases
DC7: In vivo investigation of FAP-targeting UniCAR T cell therapies combined with radio- and chemotherapy
DC8: Novel probes for imaging of tumor-associated cathepsins via Positron Emission Tomography (PET) and fluorescence microscopy
DC9: Microfluidics-based, multilevel cellular phenotyping of lymphoma cells and CAR T cells and in vivo validation
DC10: Innovative in vitro and in vivo models for TME protease research